CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 1031 - 1040 of 1136
Study Number Lead Group Study Title CIRB Study Status
NHLBI-MDS ECOG The National Myelodysplastic Syndromes (MDS) Study Cancer Prevention and Control CIRB Available to Open
MAY2016-07-01F CP-CTNet_CLO-Mayo Clinic Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01 Weekly Erlotinib for Familial Adenomatous Polyposis Cancer Prevention and Control CIRB Completed
INT21-05-01 CLO-Northwestern University Phase IIB Clinical Trial of the Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury) Vaccine (TRI-AD5) and IL-15 Superagonist N-803 in Lynch Syndrome Cancer Prevention and Control CIRB Available to Open
NRG-CC003 NRG Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with Or without Hippocampal Avoidance for Small Cell Lung Cancer Cancer Prevention and Control CIRB Available to Open
A211901 Alliance Reaching Rural Cancer Survivors Who Smoke Using Text-Based Cessation Interventions Cancer Prevention and Control CIRB Available to Open
A211701 Alliance A Prospective Study to Establish a New Onset Hyperglycemia and Diabetes (NOD) Cohort Cancer Prevention and Control CIRB Completed
NWU2014-04-01 CLO-Northwestern University Statin Therapy to Reduce the Risk of Recurrent Pancreatitis Cancer Prevention and Control CIRB Completed
A221702 Alliance ARM: Axillary Reverse Mapping – A Prospective Trial To Study Rates Of Lymphedema And Regional Reccurence After Sentinel Lymph Node Biopsy And Sentinel Lymph Node Biopsy Followed By Axillary Lymph Node Dissection With And Without Axillary Reverse Mapping Cancer Prevention and Control CIRB Available to Open
NRG-CC010 NRG A Phase III Trial of the Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Endometrial Cancer Cancer Prevention and Control CIRB Available to Open
ANBL2131 COG A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma Cancer Prevention and Control CIRB Available to Open
Displaying 1031 - 1040 of 1136